Literature DB >> 15578582

Hand involvement in Schmid metaphyseal chondrodysplasia.

Alison M Elliott1, Fiona M Field, David L Rimoin, Ralph S Lachman.   

Abstract

Schmid metaphyseal chondrodysplasia (Schmid MCD, MIM 156500) is caused by mutations in the COL10A1 gene and is clinically characterized by short stature, bowed legs, and a waddling gait. Radiographic findings include anterior cupping, sclerosis and splaying of the ribs, diffuse metaphyseal flaring, and irregularity that is most pronounced at the knees, coxa vara, and femoral bowing. We reviewed the radiographs of Schmid MCD patients at the International Skeletal Dysplasia Registry in Los Angeles for evidence of hand involvement. We found hand involvement in 47% (7/15) of cases included in our analysis. These changes were subtle and consisted of shortening of the tubular bones and metaphyseal cupping of the proximal phalanges and metacarpals. Mild hand involvement is a common feature of Schmid MCD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15578582     DOI: 10.1002/ajmg.a.30433

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  A Novel Presentation of Metaphyseal Chondrodysplasia, Schmid Type with Factor VII Deficiency.

Authors:  Mushtaq Ahmed; Saad Nasir; Syeda Shaheera Riaz Hashmi; Zia Iqbal; Ayesha Saleem
Journal:  Cureus       Date:  2020-03-23

2.  Identification of two novel COL10A1 heterozygous mutations in two Chinese pedigrees with Schmid-type metaphyseal chondrodysplasia.

Authors:  Lingchi Kong; Li Shi; Wenbo Wang; Rongtai Zuo; Mengwei Wang; Qinglin Kang
Journal:  BMC Med Genet       Date:  2019-12-19       Impact factor: 2.103

3.  Identification of a novel COL10A1: c.1952 G>T variant in a family with Schmid metaphyseal chondrodysplasia and development of a noninvasive prenatal testing method.

Authors:  Yanchou Ye; Weihao Li; Guan Wang; Longsheng Zhan; Junwei Lin; Tian Li; Jun Zhang
Journal:  Mol Genet Genomic Med       Date:  2021-08-23       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.